Evidence map›Paper›PMID 32781020›Full record

ArticleDevelopmental cell2020

Linking Matrix Rigidity with EMT and Cancer Invasion.

Manon Ros, Margaux Sala, Frédéric Saltel

Open access · bronzeAbstract readComment
PubMed Publisher
In one paragraph

Article in Developmental cell, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Manon RosINSERM, UMR1053 Bordeaux Research in Translational Oncology, BaRITOn, F-33000 Bordeaux, France; Université de Bordeaux, UMR1053 Bordeaux Research in Translational Oncology, BaRITOn, F-33000 Bordeaux, France.
Margaux SalaINSERM, UMR1053 Bordeaux Research in Translational Oncology, BaRITOn, F-33000 Bordeaux, France; Université de Bordeaux, UMR1053 Bordeaux Research in Translational Oncology, BaRITOn, F-33000 Bordeaux, France.
Frédéric SaltelINSERM, UMR1053 Bordeaux Research in Translational Oncology, BaRITOn, F-33000 Bordeaux, France; Université de Bordeaux, UMR1053 Bordeaux Research in Translational Oncology, BaRITOn, F-33000 Bordeaux, France. Electronic address: frederic.saltel@inserm.fr.
Translational Research in Oncology · FRUniversité de Bordeaux · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The extracellular matrix (ECM) plays a major role in cancer progression through its increased deposition and alignment. In this issue of Developmental Cell, Fattet et al. reveal a pathway in which ECM stiffness promotes EPHA2/LYN complex activation, leading to TWIST1 nuclear localization and triggering EMT in breast cancer.

Indexed as

Breast NeoplasmsEpithelial-Mesenchymal TransitionExtracellular MatrixHumansTwist-Related Protein 1Twist-Related Protein 1

Identifiers

PMID32781020
OpenAlexW3048888411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.